Division of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado 350-0283, Japan.
Department of Infectious Disease and Infection Control, Saitama Medical University, Moroyama 350-8550, Japan.
Int J Mol Sci. 2023 Jun 27;24(13):10698. doi: 10.3390/ijms241310698.
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), of which there are several variants. The three major variants (Alpha, Delta, and Omicron) carry the N501Y, L452R, and Q493R/Q498R mutations, respectively, in the gene. Control of COVID-19 requires rapid and reliable detection of not only SARS-CoV-2 but also its variants. We previously developed a reverse transcription loop-mediated isothermal amplification assay combined with a bioluminescent assay in real time (RT-LAMP-BART) to detect the L452R mutation in the SARS-CoV-2 spike protein. In this study, we established LAMP primers and peptide nucleic acid probes to detect N501Y and Q493R/Q498R. The LAMP primer sets and PNA probes were designed for the N501Y and Q493R/Q498R mutations on the gene of SARS-CoV-2. The specificities of RT-LAMP-BART assays were evaluated using five viral and four bacterial reference strains. The sensitivities of RT-LAMP-BART assays were evaluated using synthetic RNAs that included the target sequences, together with RNA-spiked clinical nasopharyngeal and salivary specimens. The results were compared with those of conventional real-time reverse transcription-polymerase chain reaction (RT-PCR) methods. The method correctly identified N501Y and Q493R/Q498R. Within 30 min, the RT-LAMP-BART assays detected up to 100-200 copies of the target genes; conventional real-time RT-PCR required 130 min and detected up to 500-3000 copies. Surprisingly, the real-time RT-PCR for N501Y did not detect the BA.1 and BA.2 variants (Omicron) that exhibited the N501Y mutation. The novel RT-LAMP-BART assay is highly specific and more sensitive than conventional real-time RT-PCR. The new assay is simple, inexpensive, and rapid; thus, it can be useful in efforts to identify SARS-CoV-2 variants of concern.
新型冠状病毒病 2019(COVID-19)由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起,其存在几种变体。这三种主要变体(Alpha、Delta 和 Omicron)分别在 基因上携带 N501Y、L452R 和 Q493R/Q498R 突变。控制 COVID-19 需要快速可靠地检测 SARS-CoV-2 及其变体。我们之前开发了一种逆转录环介导等温扩增检测法,结合实时生物发光检测法(RT-LAMP-BART),以检测 SARS-CoV-2 刺突蛋白中的 L452R 突变。在这项研究中,我们建立了用于检测 N501Y 和 Q493R/Q498R 的 LAMP 引物和肽核酸探针。LAMP 引物组和 PNA 探针是针对 SARS-CoV-2 基因上的 N501Y 和 Q493R/Q498R 突变设计的。使用五种病毒和四种细菌参考株评估 RT-LAMP-BART 检测法的特异性。使用包含目标序列的合成 RNA 评估 RT-LAMP-BART 检测法的灵敏度,以及 RNA 污染的临床鼻咽和唾液标本。结果与常规实时逆转录聚合酶链反应(RT-PCR)方法进行比较。该方法正确识别 N501Y 和 Q493R/Q498R。在 30 分钟内,RT-LAMP-BART 检测法可检测到高达 100-200 拷贝的靶基因;常规实时 RT-PCR 则需要 130 分钟,可检测到 500-3000 拷贝。令人惊讶的是,实时 RT-PCR 无法检测到表现出 N501Y 突变的 BA.1 和 BA.2 变体(Omicron)。新型 RT-LAMP-BART 检测法具有高度特异性,比常规实时 RT-PCR 更灵敏。新的检测法简单、便宜、快速;因此,它在识别 SARS-CoV-2 变体方面可能有用。